Effects of Intravenous Lidocaine on Quality of Recovery After Laparoscopic Bariatric Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Eduardo Cerchi BarbosaGuilherme H P C OrtegalJulia M AguirrePaola R R CostaLucas N FerreiraLaura F MoreiraGuilherme C SilvaPedro Paulo M Ferro FilhoDiogo M FerreiraPublished in: Obesity surgery (2024)
This systematic review and meta-analysis aimed to assess the effects of pre and intraoperative lidocaine infusion on short-term recovery quality after laparoscopic bariatric surgeries. In the search across MEDLINE, Embase, and Cochrane databases, we considered randomized controlled trials comparing intravenous lidocaine vs placebo (saline) for patients with obesity undergoing laparoscopic bariatric surgery. Seven studies (640 patients) were included. The lidocaine group had a significantly higher recovery quality score, a lower morphine consumption, and a notably reduced rate of nausea and vomiting compared with the placebo group. Additionally, Lidocaine infusion was associated with a shorter hospital stay, while no significant difference was observed in the time to bowel function recovery between both groups. In conclusion, lidocaine infusion before and during laparoscopic bariatric surgery contributes to an enhanced quality of recovery.
Keyphrases
- bariatric surgery
- weight loss
- robot assisted
- obese patients
- low dose
- randomized controlled trial
- end stage renal disease
- quality improvement
- high dose
- healthcare
- roux en y gastric bypass
- ejection fraction
- newly diagnosed
- chronic kidney disease
- metabolic syndrome
- emergency department
- patients undergoing
- peritoneal dialysis
- insulin resistance
- systematic review
- clinical trial
- prognostic factors
- skeletal muscle
- machine learning
- weight gain
- deep learning
- physical activity
- phase iii
- case control